Washington State Compounder Cited for Unsafe Practices

Drug Industry Daily
A A
A June FDA inspection left a Washington state pharmacy and compounder with a Form 483 citing unsafe production practices that could lead to drug contamination.

To View This Article:

Login

Subscribe To Drug Industry Daily